Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. W. Beelen
Small Interfering RNA Against BCR-ABL Transcripts Sensitize Mutated T315I Cells to Nilotinib
Haematologica
Hematology
Related publications
Anti-Leukemic Activity of Axitinib Against Cells Harboring the BCR-ABL T315I Point Mutation
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Broad Spectrum Alkynyl Inhibitors of T315I BCR-Abl
Bioorganic and Medicinal Chemistry Letters
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery
Simultaneous Targeting of Aurora Kinases and BCR-Abl Kinase by the Small Molecule Inhibitor PHA-739358 Is Effective Against Imatinib-Resistant BCR-ABL Mutations Including T315I
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Nilotinib Treatment in Mouse Models of P190 BCR/Abl Lymphoblastic Leukemia
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
The Gatekeeper Mutation T315I Confers Resistance Against Small Molecules by Increasing or Restoring the ABL-kinase Activity Accompanied by Aberrant Transphosphorylation of Endogenous BCR, Even in Loss-Of-Function Mutants of BCR/ABL
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Delivery of Therapeutic Small Interfering RNA to Tumor-Associated Immune Cells
Science-Business eXchange
A Type-Ii Kinase Inhibitor Capable of Inhibiting the T315I “Gatekeeper” Mutant of BCR-Abl
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Oligomerization Inhibition, Combined With Allosteric Inhibition, Abrogates the Transformation Potential of T315i-Positive BCR/ABL
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Protein Kinase CKIIa Interacts With the BCR Moiety of BCR/Abl and Mediates Proliferation of BCR/Abl-Expressing Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
